Leila Mousavizadeh

Infectious Diseases · 2020

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Leila Mousavizadeh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. David Gurwitz
  2. M. Hoffmann
  3. Yu Chen
  4. Hannah Kleine-Weber

Papers from Leila Mousavizadeh's perspective

Ordered by how strongly the researchers Leila Mousavizadeh trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding (The Lancet)
  2. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (Science Translational Medicine)
  3. Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans (mBio)
  4. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)
  5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  6. Emerging coronaviruses: Genome structure, replication, and pathogenesis (Journal of Medical Virology)
  7. The spike protein of SARS-CoV — a target for vaccine and therapeutic development (Nature Reviews Microbiology)
  8. Features, Evaluation and Treatment Coronavirus (COVID-19)
  9. Continuous and Discontinuous RNA Synthesis in Coronaviruses (Annual Review of Virology)
  10. Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics (Drug development research (Print))

Their papers